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Communication 
An assessment of three human methylenetetrahydrofolate 
dehydrogenase/cyclohydrolase ligand complexes following further refinement. 
Renata V. Bueno, Alice Dawson and William N. Hunter 
Division of Biological Chemistry and Drug Discovery, College of Life Sciences, 
University of Dundee, Dundee, DD1 5EH, Scotland (UK) 
Correspondence e-mail: w.n.hunter@dundee.ac.uk 
Synopsis 
Further refinement of three methylenetetrahydrofolate dehydrogenase/cyclohydrolase antifolate 
inhibitor complexes in the Protein Data Bank has produced models that allow for a critical 
reassessment of ligand placement. One complex has a well-ordered ligand in a catalytic site and 
the model provides an improved description of enzyme-inhibitor interactions. One ligand may 
adopt two conformations in the binding site rather than the single one previously described. There 
is no evidence to support incorporation of the third compound in the model. Our interpretation of 
the data supports a correlation between the models and inhibition activity for two of the 
compounds. In the case of the third, inconsistencies are noted that would need to be addressed by 
further work. 
Author Accepted Manuscript version of Bueno, Renata, Alice Dawson, and William N Hunter. "An assessment of three human methylenetetrahydrofolate 
dehydrogenase/cyclohydrolase-ligand complexes following further refinement". Acta Crystallographica Section F: Structural Biology Communications. 2019, 75(Pt 
3). 148-152. https://doi.org/10.1107/S2053230X18018083
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Abstract 
Enzymes involved in folate metabolism are key drug targets for cell growth modulation and 
accurate crystallographic structures provide templates to be exploited for structure-based ligand 
design. In this context, three ternary complex structures of human methylenetetrahydrofolate 
dehydrogenase/cyclohydrolase have been published and potentially represent starting points for 
development of new antifolate inhibitors. However, our inspection of the models and deposited 
data revealed deficiencies and raised questions about the validity of the structures. A number of 
inconsistencies relating to the publication were also identified. We carried out additional 
refinement with the deposited data, seeking to improve the models and to then validate the 
complex structures or correct the record. In one case, we support the inclusion of the inhibitor in 
the structure and alterations to the model allow us to describe details of enzyme-ligand 
interactions not previously discussed. For one weak inhibitor, the data suggest that the ligand may 
adopt two poses in the binding site both with few interactions to the enzyme. In the third case, that 
of a potent inhibitor, we note inconsistencies in the assignment of the chemical structure and no 
evidence to support inclusion of the ligand in the active site. 
Keywords: methylene-tetrahydrofolate dehydrogenase, methenyl-tetrahydrofolate cyclohydrolase, 
antifolates, structure-based ligand design. 
PDB codes: 6ECP, 6ECQ, 6ECR. 




Methylene-tetrahydrofolate dehydrogenase, methenyl-tetrahydrofolate cyclohydrolase and 10-
formyl-tetrahydrofolate synthetase support the inter-conversion of tetrahydrofolate derivatives, 
directing one-carbon donor units to biosynthesis of amino acids and nucleotides {ADDIN 
CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : 
"10.1021/bi971906t", "ISBN" : "0006-2960", "ISSN" : "00062960", "PMID" : "9454603", 
"abstract" : "The kinetic properties of three methylenetetrahydrofolate dehydrogenase-
cyclohydrolase (D/C) enzymes (the NADP-dependent bifunctional domain of the human 
cytoplasmic trifunctional enzyme, the human mitochondrial NAD-dependent bifunctional enzyme, 
and the NAD(P)-dependent bifunctional enzyme from Photobacterium phosphoreum) were 
determined in both forward and reverse directions. In the forward direction, the enzymes possess 
widely different ratios of kcat C/Kcat D, but all channel methenylH4folate produced by the D 
activity to the C activity with approximately the same efficiency. A deuterium isotope effect is 
observed with the human NADP-dependent enzyme in both forward and reverse dehydrogenase 
assays, consistent with hydride transfer being rate limiting for the interconversion of methenyl- 
and methyleneH4folate. However, no kinetic isotope effect is observed for the overall reverse 
reaction (formylH4folate to methyleneH4folate). We devised an assay to measure the reverse 
cyclohydrolase activity independent of the dehydrogenase, and determined that the Kcat (overall 
reverse) for each enzyme is approximately equal to the Kcat for its reverse cyclohydrolase 
activity. Therefore, the rate-limiting step in the overall reverse reaction is not hydride transfer by 
the dehydrogenase, but the production of methenylH4folate catalyzed by the cyclohydrolase. The 
reverse cyclohydrolase activities of the NADP-dependent D/C and the P. phosphoreum enzymes, 
but not the mitochondrial NAD-dependent enzyme, can be stimulated 2-fold by the addition of 
2',5'-ADP. The results suggest that the cyclohydrolases of the human NADP dependent and P. 
phosphoreum enzymes are optimized to catalyze the reverse reaction in the presence of bound 
coenzyme. These results imply that essentially all of the methenylH4folate produced by the 
cyclohydrolase in the reverse reaction is channeled to the dehydrogenase.", "author" : [ { 
"dropping-particle" : "", "family" : "Pawelek", "given" : "Peter D.", "non-dropping-particle" : "", 
"parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "MacKenzie", "given" : 
"Robert E.", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" } ], "container-title" : 
"Biochemistry", "id" : "ITEM-1", "issue" : "4", "issued" : { "date-parts" : [ [ "1998" ] ] }, "page" : 
"1109-1115", "title" : "Methenyltetrahydrofolate cyclohydrolase is rate limiting for the enzymatic 
conversion of 10-formyltetrahydrofolate to 5,10- methylenetetrahydrofolate in bifunctional 
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dehydrogenase-cyclohydrolase enzymes", "type" : "article-journal", "volume" : "37" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=c6033326-38e8-457b-af0e-22e8e505389d" ] } ], 
"mendeley" : { "formattedCitation" : "(Pawelek & MacKenzie, 1998)", 
"plainTextFormattedCitation" : "(Pawelek & MacKenzie, 1998)", "previouslyFormattedCitation" : 
"(Pawelek & MacKenzie, 1998)" }, "properties" : { "noteIndex" : 0 }, "schema" : 
"https://github.com/citation-style-language/schema/raw/master/csl-citation.json" }}. In humans, a 
trifunctional enzyme carries these activities. The enzyme comprises a C-terminal synthetase 
domain and an N-terminal domain possessing the dehydrogenase/cyclohydrolase (DHCH) 
activities {ADDIN CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" 
: "10.1016/S0969-2126(98)00019-7", "ISBN" : "0969-2126 (Print)\\r0969-2126 (Linking)", 
"ISSN" : "09692126", "PMID" : "9519408", "abstract" : "BACKGROUND: The interconversion 
of two major folate one-carbon donors occurs through the sequential activities of NAD(P)-
dependent methylene[H4]folate dehydrogenase (D) and methenyl[H4]folate cyclohydrolase (C). 
These activities often coexist as part of a multifunctional enzyme and there are several lines of 
evidence suggesting that their substrates bind at overlapping sites. Little is known, however, about 
the nature of this site or the identity of the active-site residues for this enzyme family. RESULTS: 
We have determined, to 1.5 A resolution, the structure of a dimer of the D/C domain of the human 
trifunctional cytosolic enzyme with bound NADP cofactor, using the MAD technique. The D/C 
subunit is composed of two alpha/beta domains that assemble to form a wide cleft. The cleft walls 
are lined with highly conserved residues and NADP is bound along one wall. The NADP-binding 
domain has a Rossmann fold, characterized by a modified diphosphate-binding loop fingerprint-
GXSXXXG. Dimerization occurs by antiparallel interaction of two NADP-binding domains. 
Superposition of the two subunits indicates domain motion occurs about a well-defined hinge 
region. CONCLUSIONS: Analysis of the structure suggests strongly that folate-binding sites for 
both activities are within the cleft, providing direct support for the proposed overlapping site 
model. The orientation of the nicotinamide ring suggests that in the dehydrogenase-catalyzed 
reaction hydride transfer occurs to the pro-R side of the ring. The identity of the cyclohydrolase 
active site is not obvious. We propose that a conserved motif-Tyr52-X-X-X-Lys56- and/or a 
Ser49-Gln100-Pro102 triplet have a role in this activity.", "author" : [ { "dropping-particle" : "", 
"family" : "Allaire", "given" : "M", "non-dropping-particle" : "", "parse-names" : false, "suffix" : 
"" }, { "dropping-particle" : "", "family" : "Li", "given" : "Y", "non-dropping-particle" : "", "parse-
names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "MacKenzie", "given" : "R E", 
"non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Cygler", "given" : "M", "non-dropping-particle" : "", "parse-names" : false, "suffix" : 
{PAGE   \* MERGEFORMAT} 
 
"" } ], "container-title" : "Structure (London, England : 1993)", "id" : "ITEM-1", "issue" : "2", 
"issued" : { "date-parts" : [ [ "1998" ] ] }, "page" : "173-182", "title" : "The 3-D structure of a 
folate-dependent dehydrogenase/cyclohydrolase bifunctional enzyme at 1.5 A resolution.", "type" 
: "article-journal", "volume" : "6" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=28554acb-b24d-498a-aad3-455cb0444111" ] } ], 
"mendeley" : { "formattedCitation" : "(Allaire <i>et al.</i>, 1998)", "plainTextFormattedCitation" 
: "(Allaire et al., 1998)", "previouslyFormattedCitation" : "(Allaire <i>et al.</i>, 1998)" }, 
"properties" : { "noteIndex" : 0 }, "schema" : "https://github.com/citation-style-
language/schema/raw/master/csl-citation.json" }}. In prokaryotes the functions are encoded either 
by three proteins or with a monofunctional synthetase and a bifunctional DHCH {ADDIN 
CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : 
"10.1002/bies.10114", "ISBN" : "1521-1878", "ISSN" : "02659247", "PMID" : "12111724", 
"abstract" : "The potential of the folic acid biosynthesis pathway as a target for the development of 
antibiotics has been acknowledged for many years and validated by the clinical use of several 
drugs. Recently, the crystal structures of all but one of the enzymes in the pathway from GTP to 
dihydrofolate have been determined. Given that structure-based drug design strategies are now 
widely employed, these recent developments have prompted a re-evaluation of the potential of 
each of the enzymes in the pathway as a target for development of specific inhibitors. Here, we 
review the current knowledge of the structure and mechanism of each enzyme in the bacterial folic 
acid biosynthesis pathway from GTP to dihydrofolate and draw conclusions regarding the 
potential of each enzyme as a target for therapeutic intervention.", "author" : [ { "dropping-
particle" : "", "family" : "Bermingham", "given" : "Alun", "non-dropping-particle" : "", "parse-
names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Derrick", "given" : "Jeremy 
P.", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" } ], "container-title" : 
"BioEssays", "id" : "ITEM-1", "issue" : "7", "issued" : { "date-parts" : [ [ "2002" ] ] }, "page" : 
"637-648", "title" : "The folic acid biosynthesis pathway in bacteria: Evaluation of potential for 
antibacterial drug discovery", "type" : "article-journal", "volume" : "24" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=1944f81b-4880-4cbc-b2d8-35515e3581fe" ] } ], 
"mendeley" : { "formattedCitation" : "(Bermingham & Derrick, 2002)", 
"plainTextFormattedCitation" : "(Bermingham & Derrick, 2002)", "previouslyFormattedCitation" 
: "(Bermingham & Derrick, 2002)" }, "properties" : { "noteIndex" : 0 }, "schema" : 
"https://github.com/citation-style-language/schema/raw/master/csl-citation.json" }}. The 
trifunctional human enzyme represents an attractive target for anticancer agents {ADDIN 
CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : "10.1158/1541-
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7786.MCR-15-0117", "ISBN" : "9780128000977", "ISSN" : "1541-7786", "PMID" : "24655651", 
"author" : [ { "dropping-particle" : "", "family" : "Tedeschi", "given" : "P. M.", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : 
"Vazquez", "given" : "A.", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { 
"dropping-particle" : "", "family" : "Kerrigan", "given" : "J. E.", "non-dropping-particle" : "", 
"parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Bertino", "given" : "J. 
R.", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" } ], "container-title" : 
"Molecular Cancer Research", "id" : "ITEM-1", "issue" : "10", "issued" : { "date-parts" : [ [ 
"2015", "10", "1" ] ] }, "page" : "1361-1366", "title" : "Mitochondrial Methylenetetrahydrofolate 
Dehydrogenase (MTHFD2) Overexpression Is Associated with Tumor Cell Proliferation and Is a 
Novel Target for Drug Development", "type" : "article-journal", "volume" : "13" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=efb1a252-fbde-4176-8981-ad51e8961271" ] } ], 
"mendeley" : { "formattedCitation" : "(Tedeschi <i>et al.</i>, 2015)", 
"plainTextFormattedCitation" : "(Tedeschi et al., 2015)", "previouslyFormattedCitation" : 
"(Tedeschi <i>et al.</i>, 2015)" }, "properties" : { "noteIndex" : 0 }, "schema" : 
"https://github.com/citation-style-language/schema/raw/master/csl-citation.json" }}. In addition, 
the bacterial enzymes represent potential targets for antibiotic development {ADDIN 
CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : 
"10.1002/bies.10114", "ISBN" : "1521-1878", "ISSN" : "02659247", "PMID" : "12111724", 
"abstract" : "The potential of the folic acid biosynthesis pathway as a target for the development of 
antibiotics has been acknowledged for many years and validated by the clinical use of several 
drugs. Recently, the crystal structures of all but one of the enzymes in the pathway from GTP to 
dihydrofolate have been determined. Given that structure-based drug design strategies are now 
widely employed, these recent developments have prompted a re-evaluation of the potential of 
each of the enzymes in the pathway as a target for development of specific inhibitors. Here, we 
review the current knowledge of the structure and mechanism of each enzyme in the bacterial folic 
acid biosynthesis pathway from GTP to dihydrofolate and draw conclusions regarding the 
potential of each enzyme as a target for therapeutic intervention.", "author" : [ { "dropping-
particle" : "", "family" : "Bermingham", "given" : "Alun", "non-dropping-particle" : "", "parse-
names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Derrick", "given" : "Jeremy 
P.", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" } ], "container-title" : 
"BioEssays", "id" : "ITEM-1", "issue" : "7", "issued" : { "date-parts" : [ [ "2002" ] ] }, "page" : 
"637-648", "title" : "The folic acid biosynthesis pathway in bacteria: Evaluation of potential for 
antibacterial drug discovery", "type" : "article-journal", "volume" : "24" }, "uris" : [ 
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"http://www.mendeley.com/documents/?uuid=1944f81b-4880-4cbc-b2d8-35515e3581fe" ] }, { 
"id" : "ITEM-2", "itemData" : { "DOI" : "10.1111/febs.12025", "ISSN" : "1742464X", "PMID" : 
"23050773", "abstract" : "The bifunctional N(5),N(10)-methylenetetrahydrofolate 
dehydrogenase/cyclohydrolase (DHCH or FolD), which is widely distributed in prokaryotes and 
eukaryotes, is involved in the biosynthesis of folate cofactors that are essential for growth and 
cellular development. The enzyme activities represent a potential antimicrobial drug target. We 
have characterized the kinetic properties of FolD from the Gram-negative pathogen Acinetobacter 
baumanni and determined high-resolution crystal structures of complexes with a cofactor and two 
potent inhibitors. The data reveal new details with respect to the molecular basis of catalysis and 
potent inhibition. A unexpected finding was that our crystallographic data revealed a different 
structure for LY374571 (an inhibitor studied as an antifolate) than that previously published. The 
implications of this observation are discussed.", "author" : [ { "dropping-particle" : "", "family" : 
"Eadsforth", "given" : "Thomas C.", "non-dropping-particle" : "", "parse-names" : false, "suffix" : 
"" }, { "dropping-particle" : "V.", "family" : "Maluf", "given" : "Fernando", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Hunter", 
"given" : "William N.", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" } ], 
"container-title" : "FEBS Journal", "id" : "ITEM-2", "issue" : "23", "issued" : { "date-parts" : [ [ 
"2012" ] ] }, "page" : "4350-4360", "title" : "Acinetobacter baumannii FolD ligand complexes - 
Potent inhibitors of folate metabolism and a re-evaluation of the structure of LY374571", "type" : 
"article-journal", "volume" : "279" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=39eaedb5-e306-4db7-8969-ab5098477c12" ] }, { 
"id" : "ITEM-3", "itemData" : { "DOI" : "10.1371/journal.pone.0035973", "ISBN" : "1932-6203 
(Electronic)\r1932-6203 (Linking)", "ISSN" : "1932-6203", "PMID" : "22558288", "abstract" : 
"<p>The bifunctional enzyme methylenetetrahydrofolate dehydrogenase \u2013 cyclohydrolase 
(FolD) is identified as a potential drug target in Gram-negative bacteria, in particular the 
troublesome <italic>Pseudomonas aeruginosa</italic>. In order to provide a comprehensive and 
realistic assessment of the potential of this target for drug discovery we generated a highly 
efficient recombinant protein production system and purification protocol, characterized the 
enzyme, carried out screening of two commercial compound libraries by differential scanning 
fluorimetry, developed a high-throughput enzyme assay and prosecuted a screening campaign 
against almost 80,000 compounds. The crystal structure of <italic>P. aeruginosa</italic> FolD 
was determined at 2.2 \u00c5 resolution and provided a template for an assessment of druggability 
and for modelling of ligand complexes as well as for comparisons with the human enzyme. New 
FolD inhibitors were identified and characterized but the weak levels of enzyme inhibition suggest 
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that these compounds are not optimal starting points for future development. Furthermore, the 
close similarity of the bacterial and human enzyme structures suggest that selective inhibition 
might be difficult to attain. In conclusion, although the preliminary biological data indicates that 
FolD represents a valuable target for the development of new antibacterial drugs, indeed spurred 
us to investigate it, our screening results and structural data suggest that this would be a difficult 
enzyme to target with respect to developing the appropriate lead molecules required to underpin a 
serious drug discovery effort.</p>", "author" : [ { "dropping-particle" : "", "family" : "Eadsforth", 
"given" : "Thomas C", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { 
"dropping-particle" : "", "family" : "Gardiner", "given" : "Mary", "non-dropping-particle" : "", 
"parse-names" : false, "suffix" : "" }, { "dropping-particle" : "V", "family" : "Maluf", "given" : 
"Fernando", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-
particle" : "", "family" : "McElroy", "given" : "Stuart", "non-dropping-particle" : "", "parse-
names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "James", "given" : "Daniel", 
"non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Frearson", "given" : "Julie", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" }, { "dropping-particle" : "", "family" : "Gray", "given" : "David", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Hunter", 
"given" : "William N", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" } ], 
"container-title" : "PLoS ONE", "id" : "ITEM-3", "issue" : "4", "issued" : { "date-parts" : [ [ 
"2012" ] ] }, "page" : "e35973", "title" : "Assessment of Pseudomonas aeruginosa N5,N10-
Methylenetetrahydrofolate Dehydrogenase - Cyclohydrolase as a Potential Antibacterial Drug 
Target", "type" : "article-journal", "volume" : "7" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=a6e1a35f-2121-4613-889b-71a3ab57b2d0" ] } ], 
"mendeley" : { "formattedCitation" : "(Bermingham & Derrick, 2002; Eadsforth, Maluf <i>et 
al.</i>, 2012; Eadsforth, Gardiner <i>et al.</i>, 2012)", "plainTextFormattedCitation" : 
"(Bermingham & Derrick, 2002; Eadsforth, Maluf et al., 2012; Eadsforth, Gardiner et al., 2012)", 
"previouslyFormattedCitation" : "(Bermingham & Derrick, 2002; Eadsforth, Maluf <i>et al.</i>, 
2012; Eadsforth, Gardiner <i>et al.</i>, 2012)" }, "properties" : { "noteIndex" : 0 }, "schema" : 
"https://github.com/citation-style-language/schema/raw/master/csl-citation.json" }}. 
 The structure of the human DHCH domain has been reported in complex with three 
inhibitors {ADDIN CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { 
"DOI" : "10.1021/bi992734y", "ISBN" : "0006-2960 (Print)\\r0006-2960 (Linking)", "ISSN" : 
"00062960", "PMID" : "10828945", "abstract" : "Enzymes involved in tetrahydrofolate 
metabolism are of particular pharmaceutical interest, as their function is crucial for amino acid and 
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DNA biosynthesis. The crystal structure of the human cytosolic methylenetetrahydrofolate 
dehydrogenase/cyclohydrolase (DC301) domain of a trifunctional enzyme has been determined 
previously with a bound NADP cofactor. While the substrate binding site was identified to be 
localized in a deep and rather hydrophobic cleft at the interface between two protein domains, the 
unambiguous assignment of catalytic residues was not possible. We succeeded in determining the 
crystal structures of three ternary DC301/NADP/inhibitor complexes. Investigation of these 
structures followed by site-directed mutagenesis studies allowed identification of the amino acids 
involved in catalysis by both enzyme activities. The inhibitors bind close to Lys56 and Tyr52, 
residues of a strictly conserved motif for active sites in dehydrogenases. While Lys56 is in a good 
position for chemical interaction with the substrate analogue, Tyr52 was found stacking against 
the inhibitors' aromatic rings and hence seems to be more important for proper positioning of the 
ligand than for catalysis. Also, Ser49 and/or Cys147 were found to possibly act as an activator for 
water in the cyclohydrolase step. These and the other residues (Gln100 and Asp125), with which 
contacts are made, are strictly conserved in THF dehydrogenases. On the basis of structural and 
mutagenesis data, we propose a reaction mechanism for both activities, the dehydrogenase and the 
cyclohydrolase.", "author" : [ { "dropping-particle" : "", "family" : "Schmidt", "given" : "Andrea", 
"non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Wu", "given" : "Haiping", "non-dropping-particle" : "", "parse-names" : false, "suffix" 
: "" }, { "dropping-particle" : "", "family" : "Mackenzie", "given" : "Robert E.", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Chen", 
"given" : "Victor J.", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { 
"dropping-particle" : "", "family" : "Bewly", "given" : "Jesse R.", "non-dropping-particle" : "", 
"parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Ray", "given" : "James 
E.", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Toth", "given" : "John E.", "non-dropping-particle" : "", "parse-names" : false, "suffix" 
: "" }, { "dropping-particle" : "", "family" : "Cygler", "given" : "Miroslaw", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" } ], "container-title" : "Biochemistry", "id" : 
"ITEM-1", "issue" : "21", "issued" : { "date-parts" : [ [ "2000" ] ] }, "page" : "6325-6335", "title" : 
"Structures of three inhibitor complexes provide insight into the reaction mechanism of the human 
methylenetetrahydrofolate dehydrogenase/cyclohydrolase", "type" : "article-journal", "volume" : 
"39" }, "uris" : [ "http://www.mendeley.com/documents/?uuid=f2912831-2d65-4e42-aac0-
bed1b313204d" ] } ], "mendeley" : { "formattedCitation" : "(Schmidt <i>et al.</i>, 2000)", 
"plainTextFormattedCitation" : "(Schmidt et al., 2000)", "previouslyFormattedCitation" : 
"(Schmidt <i>et al.</i>, 2000)" }, "properties" : { "noteIndex" : 0 }, "schema" : 
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"https://github.com/citation-style-language/schema/raw/master/csl-citation.json" }}, with 
coordinates and structure factors available in the Protein Data Bank (PDB). The structures of 
homologues, together with information on inhibitors have been exploited to inform early stage 
drug discovery targeting primitive eukaryotic parasites and bacteria {ADDIN CSL_CITATION { 
"citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : "10.1111/febs.12025", "ISSN" : 
"1742464X", "PMID" : "23050773", "abstract" : "The bifunctional N(5),N(10)-
methylenetetrahydrofolate dehydrogenase/cyclohydrolase (DHCH or FolD), which is widely 
distributed in prokaryotes and eukaryotes, is involved in the biosynthesis of folate cofactors that 
are essential for growth and cellular development. The enzyme activities represent a potential 
antimicrobial drug target. We have characterized the kinetic properties of FolD from the Gram-
negative pathogen Acinetobacter baumanni and determined high-resolution crystal structures of 
complexes with a cofactor and two potent inhibitors. The data reveal new details with respect to 
the molecular basis of catalysis and potent inhibition. A unexpected finding was that our 
crystallographic data revealed a different structure for LY374571 (an inhibitor studied as an 
antifolate) than that previously published. The implications of this observation are discussed.", 
"author" : [ { "dropping-particle" : "", "family" : "Eadsforth", "given" : "Thomas C.", "non-
dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "V.", "family" 
: "Maluf", "given" : "Fernando", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" 
}, { "dropping-particle" : "", "family" : "Hunter", "given" : "William N.", "non-dropping-particle" 
: "", "parse-names" : false, "suffix" : "" } ], "container-title" : "FEBS Journal", "id" : "ITEM-1", 
"issue" : "23", "issued" : { "date-parts" : [ [ "2012" ] ] }, "page" : "4350-4360", "title" : 
"Acinetobacter baumannii FolD ligand complexes - Potent inhibitors of folate metabolism and a 
re-evaluation of the structure of LY374571", "type" : "article-journal", "volume" : "279" }, "uris" : 
[ "http://www.mendeley.com/documents/?uuid=39eaedb5-e306-4db7-8969-ab5098477c12" ] }, { 
"id" : "ITEM-2", "itemData" : { "DOI" : "10.1021/acs.jmedchem.5b00687", "ISBN" : "1520-4804 
(Electronic)\r0022-2623 (Linking)", "ISSN" : "15204804", "PMID" : "26322631", "abstract" : 
"\u00a9 2015 American Chemical Society. The bifunctional enzyme N5,N10-
methylenetetrahydrofolate dehydrogenase/cyclo hydrolase (FolD) is essential for growth in 
Trypanosomatidae. We sought to develop inhibitors of Trypanosoma brucei FolD (TbFolD) as 
potential antiparasitic agents. Compound 2 was synthesized, and the molecular structure was 
unequivocally assigned through X-ray crystallography of the intermediate compound 3. 
Compound 2 showed an IC50 of 2.2 \u03bcM, against TbFolD and displayed antiparasitic activity 
against T. brucei (IC50 49 \u03bcM). Using compound 2, we were able to obtain the first X-ray 
structure of TbFolD in the presence of NADP+ and the inhibitor, which then guided the rational 
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design of a new series of potent TbFolD inhibitors.", "author" : [ { "dropping-particle" : "", 
"family" : "Eadsforth", "given" : "Thomas C.", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" }, { "dropping-particle" : "", "family" : "Pinto", "given" : "Andrea", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Luciani", 
"given" : "Rosaria", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { 
"dropping-particle" : "", "family" : "Tamborini", "given" : "Lucia", "non-dropping-particle" : "", 
"parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Cullia", "given" : 
"Gregorio", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-
particle" : "", "family" : "Micheli", "given" : "Carlo", "non-dropping-particle" : "De", "parse-
names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Marinelli", "given" : 
"Luciana", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-
particle" : "", "family" : "Cosconati", "given" : "Sandro", "non-dropping-particle" : "", "parse-
names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Novellino", "given" : "Ettore", 
"non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Presti", "given" : "Leonardo", "non-dropping-particle" : "Lo", "parse-names" : false, 
"suffix" : "" }, { "dropping-particle" : "", "family" : "Cordeiro Da Silva", "given" : "Anabela", 
"non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Conti", "given" : "Paola", "non-dropping-particle" : "", "parse-names" : false, "suffix" : 
"" }, { "dropping-particle" : "", "family" : "Hunter", "given" : "William N.", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Costi", 
"given" : "Maria P.", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" } ], 
"container-title" : "Journal of Medicinal Chemistry", "id" : "ITEM-2", "issue" : "20", "issued" : { 
"date-parts" : [ [ "2015" ] ] }, "page" : "7938-7948", "title" : "Characterization of 2,4-Diamino-6-
oxo-1,6-dihydropyrimidin-5-yl Ureido Based Inhibitors of Trypanosoma brucei FolD and Testing 
for Antiparasitic Activity", "type" : "article-journal", "volume" : "58" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=10611627-a00c-4cdf-8f16-edd4306da83e" ] } ], 
"mendeley" : { "formattedCitation" : "(Eadsforth, Maluf <i>et al.</i>, 2012; Eadsforth <i>et 
al.</i>, 2015)", "plainTextFormattedCitation" : "(Eadsforth, Maluf et al., 2012; Eadsforth et al., 
2015)", "previouslyFormattedCitation" : "(Eadsforth, Maluf <i>et al.</i>, 2012; Eadsforth <i>et 
al.</i>, 2015)" }, "properties" : { "noteIndex" : 0 }, "schema" : "https://github.com/citation-style-
language/schema/raw/master/csl-citation.json" }}. During this assessment we noted 
inconsistencies in the Schmidt et al. (2000) publication, and in database entries relating to the 
inhibitors that we sought to understand and/or address. The names and structures of the three 
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inhibitors together with relevant database codes (PDB code and ligand ID: 1DIA:L24, 1DIB:L34, 
1DIG:L37) and used here, are given in Figure 1.  
We attempted to use L37 as a lead molecule in inhibitor development (Eadsforth et al., 
2012a). We repeated the published synthetic route on three occasions, and our analytical data were 
in excellent agreement with that reported. This extended to the observation that a potent enzyme 
inhibitor had been prepared. High resolution crystal structures showed however that the inhibitor 
is not L37 but an isomer. We decided to investigate this discrepancy and noted several issues. 
The publication describing the structures of ternary complexes of human DHCH with 
cofactor NADP and inhibitors L24 (at 2.2 Å resolution), L34 (2.7 Å) or L37 (2.2 Å) showed 2Fo-
Fc electron density maps for L24 and L34 complexes but not for L37. It is widely accepted that 
such maps are prone to serious model bias and it seemed strange not to present the data for L37, 
this being after all a highly potent inhibitor. Individual B-factors were not refined for the 2.7 Å 
resolution structure with L34. In all three structures the occupancy of the cofactor atoms and the 
inhibitors were set at different levels, ranging from 0.1 to 0.5 in order to get B-factors comparable 
to active site residues. The chemical structures of the ligands in the PDB differ from those 
presented in the publication, an enol form is assigned in the PDB listing with a single bond 
between C4 O4 and a double bond linking N3 C4. The more reasonable keto form is given for L24 
and L34 in the paper and shown in Figure 1. However, the chemical shown in the paper for L37 is 
inconsistent lacking a ring carbonyl in one figure, but present in another and in the PDB entry.  
We next inspected the coordinates. The PDB coordinates for the ligands L24 and L37 have 
carbon oxygen separations at C4 O4 of around 1.24 Å, appropriate for a double bond and 
compatible with keto forms, in L34 a C4 O4 distance of 1.39 Å suggests that restraints more 
appropriate for an enol form may have been used. The model of L37 places two hydrogen bond 
donor groups, approximately 2.2 Å apart, which is implausible. Moreover, very few contacts exist 
between the enzyme and L37 which is surprising given the high potency inhibition, Ki 3 nM, 
reported. The complex with L24 displayed steric clash, i.e short contacts incompatible with 
established chemical principles, with the cofactor and also with main chain groups in the binding 
site. On the other hand the complex with L34 had sensible hydrogen bond donor and acceptor 
groups positioned to interact but with distances 3.5 Å or greater, and non-optimal alignments. We 
therefore decided to re-assess the three structures after carrying out further refinements. 
 
2.0 Methods 
Coordinates and structure factor data for the PDB entries 1DIA, 1DIB and 1DIG were 
inspected and compared with those output from PDB-REDO, an automated refinement process 
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designed to improve crystallographic models (Joosten et al., 2009, Touw et al., 2016). In common 
with our previous experience (Rimsa et al., 2014, de Souza et al., 2017), the PDB-REDO models 
were identified as being significantly improved, and provided the starting point for further 
refinement. Although the PDB-REDO automated pipeline had significantly improved model 
geometry, the assessment and inspection of difference and electron density maps revealed strong  
features were still present and that the low occupancies of ligands had been retained. PDB-REDO 
addresses aspects of the protein structure not ligands. We removed the ligands and initiated rounds 
of electron and difference density map inspection, and refinement. Difference Fourier syntheses 
were interpreted and then, where justified, ligands were included with full occupancy and, for all 
three structures, we refined individual B-factors with restraints. The geometrical restraints for 
ligands were generated using the GRADE Web Server v.1.2.13 (www.globalphasing.com, Smart 
et al., 2011). Since these ligands were already included in the PDB chemical components 
dictionary, the three-letter code for each of them were used as input to run GRADE, which 
accesses the compound information from RCSB Ligand Expo server and generates the geometry 
restraints based on the Cambridge Structural Database repository, where available, and uses the 
quantum mechanics semi empirical molecular orbital model RM1 to generate restraints that are 
not represented in the CSD (Smart et al., 2011). These restraints were then checked to ensure 
agreement with the structures shown in Figure 1. The water molecules from PDB-REDO were 
used as a starting point and were inspected. Several were removed and then additional solvent 
molecules included. Initial inspections revealed that antifolate binding only occurred in one of the 
two active sites in the asymmetric unit for the complexes with L24 and L34, and overlay of the 
two polypeptide chains indicated that non-crystallographic symmetry was not strictly maintained 
in any of the structures hence we did not employ such restraints in refinement. However, as part of 
the review process we were encouraged to investigate the effect of the use of non-crystallographic 
symmetry restraints in the form of local structure symmetry restraints. This reduced the Rfree 
values we had obtained and a further comment on this subject is made below. Model manipulation 
and map inspections were performed using COOT (Emsley & Cowtan, 2004) and least-squares 
refinement calculations used REFMAC {ADDIN CSL_CITATION { "citationItems" : [ { "id" : 
"ITEM-1", "itemData" : { "DOI" : "10.1107/S0907444904019158", "ISBN" : "0907-4449 
(Print)\\n0907-4449 (Linking)", "ISSN" : "09074449", "PMID" : "15572765", "abstract" : 
"CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, 
providing tools for X-ray structure solution, structure comparison and analysis, and publication-
quality graphics. The map-fitting tools are available as a stand-alone package, distributed as 
'Coot'.", "author" : [ { "dropping-particle" : "", "family" : "Emsley", "given" : "Paul", "non-
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dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : 
"Cowtan", "given" : "Kevin", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" } ], 
"container-title" : "Acta Crystallographica Section D: Biological Crystallography", "id" : "ITEM-
1", "issue" : "12 I", "issued" : { "date-parts" : [ [ "2004" ] ] }, "page" : "2126-2132", "publisher" : 
"International Union of Crystallography", "title" : "Coot: Model-building tools for molecular 
graphics", "type" : "article-journal", "volume" : "60" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=6a3ed0c2-1609-4088-a8ed-0318d8a63f27" ] }, { 
"id" : "ITEM-2", "itemData" : { "DOI" : "10.1107/S0907444911001314", "ISBN" : 
"0907444911001", "ISSN" : "09074449", "PMID" : "21460454", "abstract" : "This paper 
describes various components of the macromolecular crystallographic refinement program 
REFMAC5, which is distributed as part of the CCP4 suite. REFMAC5 utilizes different likelihood 
functions depending on the diffraction data employed (amplitudes or intensities), the presence of 
twinning and the availability of SAD/SIRAS experimental diffraction data. To ensure chemical 
and structural integrity of the refined model, REFMAC5 offers several classes of restraints and 
choices of model parameterization. Reliable models at resolutions at least as low as 
4\u2005\u00c5 can be achieved thanks to low-resolution refinement tools such as secondary-
structure restraints, restraints to known homologous structures, automatic global and local NCS 
restraints, `jelly-body' restraints and the use of novel long-range restraints on atomic displacement 
parameters (ADPs) based on the Kullback-Leibler divergence. REFMAC5 additionally offers TLS 
parameterization and, when high-resolution data are available, fast refinement of anisotropic 
ADPs. Refinement in the presence of twinning is performed in a fully automated fashion. 
REFMAC5 is a flexible and highly optimized refinement package that is ideally suited for 
refinement across the entire resolution spectrum encountered in macromolecular crystallography.", 
"author" : [ { "dropping-particle" : "", "family" : "Murshudov", "given" : "Garib N.", "non-
dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : 
"Skub\u00e1k", "given" : "Pavol", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" 
}, { "dropping-particle" : "", "family" : "Lebedev", "given" : "Andrey a.", "non-dropping-particle" 
: "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Pannu", "given" : 
"Navraj S.", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-
particle" : "", "family" : "Steiner", "given" : "Roberto a.", "non-dropping-particle" : "", "parse-
names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Nicholls", "given" : "Robert 
a.", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Winn", "given" : "Martyn D.", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" }, { "dropping-particle" : "", "family" : "Long", "given" : "Fei", "non-dropping-
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particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Vagin", 
"given" : "Alexei a.", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" } ], 
"container-title" : "Acta Crystallographica Section D: Biological Crystallography", "id" : "ITEM-
2", "issue" : "4", "issued" : { "date-parts" : [ [ "2011" ] ] }, "page" : "355-367", "title" : 
"REFMAC5 for the refinement of macromolecular crystal structures", "type" : "article-journal", 
"volume" : "67" }, "uris" : [ "http://www.mendeley.com/documents/?uuid=94c35ed1-a520-4d5f-
b8be-e4b014c2960d" ] } ], "mendeley" : { "formattedCitation" : "(Emsley & Cowtan, 2004; 
Murshudov <i>et al.</i>, 2011)", "plainTextFormattedCitation" : "(Emsley & Cowtan, 2004; 
Murshudov et al., 2011)", "previouslyFormattedCitation" : "(Emsley & Cowtan, 2004; Murshudov 
<i>et al.</i>, 2011)" }, "properties" : { "noteIndex" : 0 }, "schema" : "https://github.com/citation-
style-language/schema/raw/master/csl-citation.json" }}. Model geometry was assessed using 
MolProbity {ADDIN CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { 
"DOI" : "10.1107/S0907444909042073", "ISBN" : "0907-4449", "ISSN" : "09074449", "PMID" : 
"20057044", "abstract" : "MolProbity is a structure-validation web service that provides broad-
spectrum solidly based evaluation of model quality at both the global and local levels for both 
proteins and nucleic acids. It relies heavily on the power and sensitivity provided by optimized 
hydrogen placement and all-atom contact analysis, complemented by updated versions of 
covalent-geometry and torsion-angle criteria. Some of the local corrections can be performed 
automatically in MolProbity and all of the diagnostics are presented in chart and graphical forms 
that help guide manual rebuilding. X-ray crystallography provides a wealth of biologically 
important molecular data in the form of atomic three-dimensional structures of proteins, nucleic 
acids and increasingly large complexes in multiple forms and states. Advances in automation, in 
everything from crystallization to data collection to phasing to model building to refinement, have 
made solving a structure using crystallography easier than ever. However, despite these 
improvements, local errors that can affect biological interpretation are widespread at low 
resolution and even high-resolution structures nearly all contain at least a few local errors such as 
Ramachandran outliers, flipped branched protein side chains and incorrect sugar puckers. It is 
critical both for the crystallographer and for the end user that there are easy and reliable methods 
to diagnose and correct these sorts of errors in structures. MolProbity is the authors' contribution 
to helping solve this problem and this article reviews its general capabilities, reports on recent 
enhancements and usage, and presents evidence that the resulting improvements are now 
beneficially affecting the global database.", "author" : [ { "dropping-particle" : "", "family" : 
"Chen", "given" : "Vincent B.", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, 
{ "dropping-particle" : "", "family" : "Arendall", "given" : "W. Bryan", "non-dropping-particle" : 
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"", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Headd", "given" : 
"Jeffrey J.", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-
particle" : "", "family" : "Keedy", "given" : "Daniel A.", "non-dropping-particle" : "", "parse-
names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Immormino", "given" : 
"Robert M.", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-
particle" : "", "family" : "Kapral", "given" : "Gary J.", "non-dropping-particle" : "", "parse-names" 
: false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Murray", "given" : "Laura W.", "non-
dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : 
"Richardson", "given" : "Jane S.", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" 
}, { "dropping-particle" : "", "family" : "Richardson", "given" : "David C.", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" } ], "container-title" : "Acta Crystallographica 
Section D: Biological Crystallography", "id" : "ITEM-1", "issue" : "1", "issued" : { "date-parts" : [ 
[ "2010" ] ] }, "page" : "12-21", "publisher" : "International Union of Crystallography", "title" : 
"MolProbity: All-atom structure validation for macromolecular crystallography", "type" : "article-
journal", "volume" : "66" }, "uris" : [ "http://www.mendeley.com/documents/?uuid=9584c613-
fb1d-4d1c-b5b7-34b89c826b41" ] } ], "mendeley" : { "formattedCitation" : "(Chen <i>et al.</i>, 
2010)", "plainTextFormattedCitation" : "(Chen et al., 2010)", "previouslyFormattedCitation" : 
"(Chen <i>et al.</i>, 2010)" }, "properties" : { "noteIndex" : 0 }, "schema" : 
"https://github.com/citation-style-language/schema/raw/master/csl-citation.json" }} and the PDB 
validation server (validate-rcsb-2.wwpdb.org). All coordinates were checked against the structure 
factor data using the sf-tool web server (sf-tool.wwwpdb.org), the density correlation was 
calculated using MAPMAN (Jones and Thirup, 1986) and REFMAC. The models were deposited 
in the PDB. Figures were generated by Pymol (v.1.3, {ADDIN CSL_CITATION { "citationItems" 
: [ { "id" : "ITEM-1", "itemData" : { "author" : [ { "dropping-particle" : "", "family" : 
"Schrodinger", "given" : "LLC", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" } 
], "id" : "ITEM-1", "issued" : { "date-parts" : [ [ "0" ] ] }, "title" : "The Pymol Molecular Graphics 
System, Version 1.3", "type" : "article" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=56dd8fe8-ca50-423a-a75f-7ceaee007cc6" ] } ], 
"mendeley" : { "formattedCitation" : "(Schrodinger)", "manualFormatting" : "(Schrodinger, 
LLC)", "plainTextFormattedCitation" : "(Schrodinger)", "previouslyFormattedCitation" : 
"(Schrodinger)" }, "properties" : { "noteIndex" : 0 }, "schema" : "https://github.com/citation-style-
language/schema/raw/master/csl-citation.json" }}. The crystallographic statistics for the original 
PDB entries, the PDB-REDO starting model and arising from this study are given in 
supplementary material, Tables S1, S2, S3 for 1DIA, 1DIB, 1DIG respectively. 
{PAGE   \* MERGEFORMAT} 
 
 
3.0 Results and Discussion 
3.1 Overall structure and initial comments 
Three isomorphous, medium resolution crystal structures of human DHCH were determined in 
space group P212121 with a dimer in the asymmetric unit {ADDIN CSL_CITATION { 
"citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : "10.1021/bi992734y", "ISBN" : 
"0006-2960 (Print)\\r0006-2960 (Linking)", "ISSN" : "00062960", "PMID" : "10828945", 
"abstract" : "Enzymes involved in tetrahydrofolate metabolism are of particular pharmaceutical 
interest, as their function is crucial for amino acid and DNA biosynthesis. The crystal structure of 
the human cytosolic methylenetetrahydrofolate dehydrogenase/cyclohydrolase (DC301) domain of 
a trifunctional enzyme has been determined previously with a bound NADP cofactor. While the 
substrate binding site was identified to be localized in a deep and rather hydrophobic cleft at the 
interface between two protein domains, the unambiguous assignment of catalytic residues was not 
possible. We succeeded in determining the crystal structures of three ternary 
DC301/NADP/inhibitor complexes. Investigation of these structures followed by site-directed 
mutagenesis studies allowed identification of the amino acids involved in catalysis by both 
enzyme activities. The inhibitors bind close to Lys56 and Tyr52, residues of a strictly conserved 
motif for active sites in dehydrogenases. While Lys56 is in a good position for chemical 
interaction with the substrate analogue, Tyr52 was found stacking against the inhibitors' aromatic 
rings and hence seems to be more important for proper positioning of the ligand than for catalysis. 
Also, Ser49 and/or Cys147 were found to possibly act as an activator for water in the 
cyclohydrolase step. These and the other residues (Gln100 and Asp125), with which contacts are 
made, are strictly conserved in THF dehydrogenases. On the basis of structural and mutagenesis 
data, we propose a reaction mechanism for both activities, the dehydrogenase and the 
cyclohydrolase.", "author" : [ { "dropping-particle" : "", "family" : "Schmidt", "given" : "Andrea", 
"non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Wu", "given" : "Haiping", "non-dropping-particle" : "", "parse-names" : false, "suffix" 
: "" }, { "dropping-particle" : "", "family" : "Mackenzie", "given" : "Robert E.", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Chen", 
"given" : "Victor J.", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { 
"dropping-particle" : "", "family" : "Bewly", "given" : "Jesse R.", "non-dropping-particle" : "", 
"parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Ray", "given" : "James 
E.", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Toth", "given" : "John E.", "non-dropping-particle" : "", "parse-names" : false, "suffix" 
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: "" }, { "dropping-particle" : "", "family" : "Cygler", "given" : "Miroslaw", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" } ], "container-title" : "Biochemistry", "id" : 
"ITEM-1", "issue" : "21", "issued" : { "date-parts" : [ [ "2000" ] ] }, "page" : "6325-6335", "title" : 
"Structures of three inhibitor complexes provide insight into the reaction mechanism of the human 
methylenetetrahydrofolate dehydrogenase/cyclohydrolase", "type" : "article-journal", "volume" : 
"39" }, "uris" : [ "http://www.mendeley.com/documents/?uuid=f2912831-2d65-4e42-aac0-
bed1b313204d" ] } ], "mendeley" : { "formattedCitation" : "(Schmidt <i>et al.</i>, 2000)", 
"plainTextFormattedCitation" : "(Schmidt et al., 2000)", "previouslyFormattedCitation" : 
"(Schmidt <i>et al.</i>, 2000)" }, "properties" : { "noteIndex" : 0 }, "schema" : 
"https://github.com/citation-style-language/schema/raw/master/csl-citation.json" }}. Each subunit 
contains 296 residues, ten -helices and nine -strands forming two domains. The C-terminal 
domain presents a Rossmann fold involved in cofactor binding. The adenine moiety is buried into 
a hydrophobic pocket, and the nicotinamide ring in a cleft between the C-terminal and N-terminal 
domains. The catalytic site for substrate (N5, N10-methylene-tetrahydrofolate methylene) binding 
resides in the N-terminal domain. Each active site binds the cofactor NADP, but inhibitor binding 
is confined to only one. For all three structures the crystallographic statistics (Supporting 
Information, Tables S1-3) indicate that PDB-REDO made significant improvements to model 
geometry and fit to the diffraction data. The models that result from our extension to the 
refinement are essentially the same as the PDB-REDO models, with differences mainly confined 
to the ligands. The maps were good enough to justify the addition of two residues of a flexible 
loop (residues 240-250) in chain A of entries 1DIA and 1DIB. In all cases, the density correlation 
function has improved (Supporting Information, Table S4). 
 
3.1 The cofactor 
In PDB entries 1DIA, 1DIB and 1DIG the NADP occupancies had been adjusted to values lower 
than one. We obtained a satisfactory refinement using full occupancy and this improved the 
density correlation (Table S4), and resulted in acceptable B-factors that are comparable with the 
overall B-factors of the protein atoms (Supporting Information, Tables S1-3). The placement and 
conformation of the cofactors is not significantly different from those previously reported. 
 
3.2 L34 
Despite this structure being associated with the lowest resolution data set, 2.7 Å, different Fourier 
syntheses were unambiguous (e.g. Figure 1). Density for the ligand is well defined and it refined 
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satisfactorily with full occupancy. We, appear to be more conservative than the original authors 
and included fewer water molecules in the model. The density correlation coefficient increased 
from 0.77 to 0.87, but Rfree increased from 0.241 to 0.260 when the refinement, which did not 
employ non-crystallographic symmetry restraints, converged. The inclusion of local structure 
symmetry restraints then reduced the Rfree to 0.247. The Rfree values for the original structure and 
the PDB-REDO model were 0.240 and 0.241, respectively. The model displays improved 
geometry for chemical interactions in the active site with the ligand now positioned closer to key 
residues (Figure 2). The L34 N1 and N8 distances to Leu101 N and O are reduced to 3.2 Å and 3.0 
Å from 3.7 Å and 3.5 Å, an appropriate separation for hydrogen bonding interactions not 
described previously. In addition, our model now has both oxygen atoms on the side chain of 
Asp125 forming hydrogen-bonding interactions with L34. The general features of enzyme-ligand 
interactions remain similar and consistent with the observation that L34 is a potent inhibitor of the 
enzyme with Ki of 30 nM (Schmidt et al., 2000). 
 
3.3 L24 
Here, although Fourier syntheses indicate that a ligand may be present in the active site, they do 
not identify a single well-defined pose and features in difference maps following the refinement of 
different poses suggested that two orientations might be present, one of which was identified in 
the original work (Figure 1). We refined two poses of L24 each with occupancy 0.5. We note that 
the overall L24 B-factor for the two orientations are approximately twice and five times that of the 
overall B-factor for protein atoms. In both orientations the aromatic head group is positioned 
further out of the binding site compared to L34. A lack of interactions with the protein would be in 
agreement with the observation that L24 is only a weak inhibitor with Ki around 30 M (Schmidt 
et al., 2000). Although our refinement has reduced the steric clashes present in the entry 1DIA, we 
suggest that further experimental work concentrating on sample preparation might be required to 
pursue an improved structure of this inhibitor in complex with the enzyme. 
 
3.4 L37 
This molecule was reported to possess a Ki against the human enzyme of about 3 nM (Schmidt et 
al., 2000). We previously raised questions about the assignment of the chemical structure of L37, 
a compound that has been patented (company code: LY374571) and which progressed into clinical 
trials. We made three attempts to repeat the synthesis of L37 using the published protocol, and 
succeeded only in obtaining an isomer (PDB ligand code: 9L9). It is possible that, for reasons 
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unknown, we were unable to repeat the reported synthesis. An alternative explanation is that the 
original researchers did not prepare L37 but rather they themselves first synthesized the isomer. 
The analytical data reported for the isomers does not distinguish between them and we were only 
alerted to the discrepancy when we determined a high-resolution crystal structure (Eadsforth et al., 
2012). A reason to further investigate the published L37 complex was to seek out data in support 
of the L37 structure. However, the question as to whether this molecule has actually been 
synthesized and characterized remains open. Irrespective of that, our interpretation of the human 
enzyme crystallographic data is that no well-ordered inhibitor, neither L37 or 9L9, is present in the 
structure and the data then represents a binary complex with the cofactor NADP. We placed a 
number of water molecules in the active site. Some of these match to the positions of potential 
hydrogen bonding functional groups of the putative ligand in the entry 1DIG. 
 
4.0 Conclusions 
The PDB is an extremely valuable resource for biochemical and medicinal chemistry research 
(Burley et al., 2017) but unfortunately, serious errors in ligand-protein complexes have been 
reported (Wlodawer et al., 2018). For our own part, we previously showed that in structures of 
human peroxisome proliferator-activated receptors- the fatty acid binding site is occupied by 
endogenous ligands derived from the bacterial expression system and not lipid-lowering synthetic 
agents (Fyffe et al., 2006). In the glutaminase domain of Trypanosoma brucei CTP synthetase we 
corrected the stereochemistry of the inhibitor acivicin, which completely changes the description 
of interactions that stabilize the covalent complex (de Souza et al., 2017). In the case discussed 
here, of three DHCH ligand complexes, we have deposited models in the PDB following further 
refinement and with our interpretation of the data. They are therefore available to researchers with 
interests in development of antifolates. Perhaps of most value will be the negative result relating to 
L37. Since the placement of the potent inhibitor reported in PDB entry 1DIG is not substantiated 
by the crystallographic data then that structure should not be used to guide ligand development.  
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Figure 1. The structures and names of DHCH inhibitors discussed in this work. A. L34 is 
(2S)-2-[[4-[(6aR)-3-amino-1,9-dioxo-5,6,6a,7-tetrahydro-4H-imidazo[1,5-f]pteridin-8-
yl]benzoyl]amino]pentanedioic acid. L24 is (2R)-2-[[4-[2-[(6R)-2-amino-4-oxo-5,6,7,8-
tetrahydro-1H-pyrido[2,3-d]pyrimidin-6-yl]ethyl]benzoyl]amino]pentanedioic acid. L37 is (2R)-2-
[[4-[(2,5-diamino-4-oxo-1H-pyrimidin-6-yl)carbamoylamino]benzoyl]amino]pentanedioic acid. 
B. Omit Fo-Fc Polder maps (Liebschner et al., 2017) contoured at 3.0 r.m.s.d. after additional 
refinements. These omit maps were generated using the observed structure factors Fo of each 
model, and the calculated structure factors Fc generated after setting zero occupancies to the 
inhibitors, and removing the bulk solvent correction. The omit map for 1ECQ is presented with 
the L24 pteridine ring in two orientations: white carbon sticks represents L24 pteridine ring in the 
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same orientation as presented in 1DIA and pink carbon sticks represents the pteridine ring 180° 




Figure 2. Potential hydrogen bonding interactions between the inhibitor L34 and Lys56, 
Leu101, Asp125 and Gly273. For comparative purposes, the models 6ECQ and 1DIB are 
superimposed. Carbon positions associated with 6ECQ are colored grey, those with 1DIB 
brown. All oxygen and nitrogen positions are red and blue respectively. Distance 
measurements (in Å) are represented as black dashed lines. 
 
 
 
